Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...
Generative AI aids in preventive cardiology by generating patient messages, interpreting data, and addressing healthcare access and treatment gaps, though misinformation remains a concern. Wearable ...
DENVER--(BUSINESS WIRE)--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The ...
Leveraging Advanced AI and 3D Modeling, Heartflow Provides Cardiologists with Non-Invasive Analysis for Accurate Coronary Artery Disease Detection and Optimized Patient Care ORLANDO, Fla., March 24, ...
Panelists discuss desired innovations in health care technology, as well as incentives to further integrate these new technologies into patient care. Stay ahead of policy, cost, and value—subscribe to ...
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
Jun 10, 2025, 8:35 AM ETCardio Diagnostics Holdings, Inc. (CDIO) “We are proud to support this important innovation from the University of Iowa ecosystem,” said Marie Kerbeshian, Ph.D., Executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results